CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Metastatic Castration-Resistant Prostate Cancer
Oncology Nursing News
Precision Medicine in Oncology
Soft Tissue Sarcoma
Special Reports in Personalized Cancer Care
Online Continuing Education Activities
SELECT A TOPIC
Hematologic Malignancies Videos
Dr. Woyach on Phase II Trial of MOR208 Trial in CLL
Jennifer A. Woyach, MD, an associate professor of Medicine in the Division of Internal Medicine at The Ohio State University Comprehensive Cancer Center, discusses a phase II trial of the CD19-directed antibody MOR208 in combination with lenalidomide (Revlimid) or ibrutinib (Imbruvica) in patients with CLL.
Dr. Herrera on Next Steps of Drug Combinations for Hodgkin Lymphoma
Alex Herrera, MD, assistant professor, Department of Hematology and Hematologic Cell Transplantation, City of Hope, discusses next steps for a phase I/II study of brentuximab vedotin (Adcetris) in combination with nivolumab (Opdivo) in patients with relapsed or refractory Hodgkin lymphoma.
Transplantation Candidacy in MDS
Panelists Vinod Pullarkat, MD; Rami S. Komrokji, MD; Jamile Shammo, MD; and Ellen K. Ritchie, MD, describe who should be referred to a transplant center for consultation and the factors used to determine eligibility for stem cell transplant in myelodysplastic syndrome.
Myelodysplastic Syndrome: Managing Risk and Complications
Emerging Therapies for Acute Myeloid Leukemia
Panelists Elias Jabbour, MD; Martin S. Tallman, MD; Mark J. Levis, MD, PhD; Richard M. Stone, MD; and Harry P. Erba, MD, PhD, provide insight on the emerging therapies for acute myeloid leukemia and their thoughts on the growing treatment paradigm.
Moving Toward Precision Medicine in Adult Acute Myeloid Leukemia
Dr. Tallman on the State of the Science in AML Treatment
Martin S. Tallman, MD, hematologic oncologist, chief of Leukemia Service, Memorial Sloan Kettering Cancer Center, discusses the state of the science with regards to treatment of patients with acute myeloid leukemia (AML).
Dr. Ansell on PD-1 Inhibitors in Hodgkin Lymphoma
Stephen M. Ansell, MD, PhD, of Mayo Clinic, discusses the use of PD-1 inhibitors for patients with Hodgkin lymphoma.
Managing Ibrutinib Toxicity in CLL
Panelists Leo I. Gordon, MD; John Byrd, MD; and Michael J. Keating, MB, BS, provide insight on managing ibrutinib toxicity in patients with chronic lymphocytic leukemia.
Evolving Treatment Paradigms for B-Cell Non-Hodgkin Lymphoma
Choosing Triplet Therapy at Myeloma Relapse
Because there are several ongoing trials testing various combinations of treatments in multiple myeloma, Amrita Krishnan, MD; Sagar Lonial, MD; Paul Richardson, MD; Keith Stewart, MB, CHB; and Saad Usmani, MD, highlight the most beneficial triplet therapy regimens, based on current data, and advise of toxicities and adverse events associated with certain combinations of treatment.
Treatment of Multiple Myeloma in 2017 and Beyond
Dr. Thompson on Advancements in Treatments of Multiple Myeloma
Michael A. Thompson, MD, PhD, medical director, precision medicine, Vince Lombardi Cancer Clinic, Aurora Health Care, discusses advancements of treatments for patients with multiple myeloma.
Dr. Straus on Ongoing Clinical Trials in Hodgkin Lymphoma
David J. Straus, MD, an internist and hematologic oncologist at Memorial Sloan Kettering Cancer Center, discusses ongoing clinical trials in the field of Hodgkin lymphoma.
Next Page >>
FDA Approval Sought in ALL, Early 2017 GU Symposium Highlights, and New HHS Secretary Confirmed
Elderly Patients With Myeloma
Ipilimumab Broadens Nivolumab Activity in Urothelial Cancer
Transplant Remains Pivotal in Myeloma, Other Hematologic Cancers
Olaparib, Durvalumab Combo Active in Prostate Cancer
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2017
Intellisphere, LLC. All Rights Reserved.